Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Entrada Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TRDA
Nasdaq
8731
https://www.entradatx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Entrada Therapeutics Inc
Director Peter Kim Acquires 9,048 Shares of Entrada Therapeutics Inc (TRDA)
- Mar 27th, 2024 5:27 am
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Just Slashed This Year's Estimates
- Mar 19th, 2024 10:28 am
Entrada Therapeutics Inc (TRDA) Reports Solid Financial Position and Advancements in Clinical Trials
- Mar 15th, 2024 9:31 am
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
- Mar 13th, 2024 11:00 am
Entrada Therapeutics to Present at Upcoming Investor Conferences
- Feb 7th, 2024 12:00 pm
‘Time to Pull the Trigger,’ Says Oppenheimer About These 3 Stocks
- Jan 29th, 2024 1:14 pm
Amicus (FOLD) Issues Preliminary Revenue Results for FY23
- Jan 8th, 2024 2:40 pm
Collegium (COLL) Shares Rise on Financial Outlook for 2024
- Jan 4th, 2024 3:40 pm
Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO
- Jan 4th, 2024 2:46 pm
BEAM Stock Rallies More Than 25% in 3 Months: What Next?
- Jan 3rd, 2024 3:52 pm
Entrada Therapeutics Promotes Nathan J. Dowden to President
- Jan 3rd, 2024 12:00 pm
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
- Dec 29th, 2023 2:48 pm
Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug
- Dec 28th, 2023 4:13 pm
Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody
- Dec 28th, 2023 4:07 pm
Entrada Therapeutics Inc CFO Kory Wentworth Sells 12,500 Shares
- Dec 28th, 2023 12:01 pm
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
- Dec 26th, 2023 4:32 pm
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis
- Dec 26th, 2023 3:51 pm
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
- Dec 22nd, 2023 3:07 pm
argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study
- Dec 21st, 2023 2:50 pm
Roche's (RHHBY) sBLA for Xolair Gets FDA Priority Review Tag
- Dec 20th, 2023 4:24 pm
Scroll